Hetika Vora Patel

4PUBLICATIONS
31CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 25, 2026
Farnesyl transferase inhibitor KO-2806 (darlifarnib) enhances the anti-tumor activity of tyrosine kinase inhibitors in RCC.

Jovylyn G Gasendo, Stacia Chan, Hetika V Patel

|Feb 09, 2026
The Farnesyl Transferase Inhibitor Darlifarnib (KO-2806) Resensitizes Relapsing Tumors to RAS Inhibition.

Hetika Vora Patel, Alison Elizabeth Smith, Stacia Chan

|Jun 23, 2020
Inhibition of NRAS Signaling in Melanoma through Direct Depalmitoylation Using Amphiphilic Nucleophiles.

Hetika D Vora, Mai Johnson, Roberto J Brea

Pageof 1